FDA Approved: MULTAQ — Original Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

FDA approved MULTAQ (dronedarone) from Sanofi-Aventis U.S. LLC as the original application. It is indicated to reduce the risk of cardiovascular hospitalization…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Multaq (dronedarone)

Snippet

ORIG AP for MULTAQ (DRONEDARONE)